Accuray Incorporated Stock Alpha and Beta Analysis
| ARAY Stock | USD 1.83 0.09 5.17% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Accuray Incorporated. It also helps investors analyze the systematic and unsystematic risks associated with investing in Accuray Incorporated over a specified time horizon. Remember, high Accuray Incorporated's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Accuray Incorporated's market risk premium analysis include:
Beta 1.85 | Alpha 0.19 | Risk 3.93 | Sharpe Ratio (0.01) | Expected Return (0.03) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Accuray |
Accuray Incorporated Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Accuray Incorporated market risk premium is the additional return an investor will receive from holding Accuray Incorporated long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Accuray Incorporated. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Accuray Incorporated's performance over market.| α | 0.19 | β | 1.85 |
Accuray Incorporated expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Accuray Incorporated's Buy-and-hold return. Our buy-and-hold chart shows how Accuray Incorporated performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Accuray Incorporated Market Price Analysis
Market price analysis indicators help investors to evaluate how Accuray Incorporated stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Accuray Incorporated shares will generate the highest return on investment. By understating and applying Accuray Incorporated stock market price indicators, traders can identify Accuray Incorporated position entry and exit signals to maximize returns.
Accuray Incorporated Return and Market Media
The median price of Accuray Incorporated for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 2.09 with a coefficient of variation of 9.79. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 2.09, and mean deviation of 0.17. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Heres Why You Should Retain DexCom Stock in Your Portfolio for Now | 12/13/2024 |
2 | Stryker Stock Falls Despite the Agreement to Acquire Inari Medical | 01/07/2025 |
3 | Leonel Peralta to Join Accuray as Chief Operations Officer | 01/21/2025 |
4 | Insider Trading | 02/03/2025 |
5 | Accuray GAAP EPS of 0.02 beats by 0.05, revenue of 116.2M beats by 5.84M | 02/05/2025 |
6 | Accuray Q2 Earnings Taking a Look at Key Metrics Versus Estimates | 02/06/2025 |
7 | Medical Robotics Market Size to Reach USD 63.84 Billion by 2032, at 16.19 percent CAGR SNS Insider | 02/12/2025 |
8 | Radiation Therapy Market Size to Achieve USD 12.93 Bn by 2034 | 02/20/2025 |
9 | Kovack Advisors Inc. Sells 35,100 Shares of Accuray Incorporated | 02/27/2025 |
10 | Heres Why You Should Hold Accuray Stock in Your Portfolio for Now | 03/05/2025 |
11 | Robotic Radiotherapy Market is expected to generate a revenue of USD 2.95 Billion by 2032, Globally, at 11.6 percent CAGR Verified Market Research | 03/11/2025 |
12 | Accuray Is Experiencing Growth In Returns On Capital | 03/13/2025 |
13 | Acquisition by Scott Byron C of 59055 shares of Accuray Incorporated subject to Rule 16b-3 | 03/14/2025 |
About Accuray Incorporated Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Accuray or other stocks. Alpha measures the amount that position in Accuray Incorporated has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 60.98 | 75.2 | 67.68 | 56.0 | PTB Ratio | 6.84 | 3.84 | 3.45 | 1.94 |
Accuray Incorporated Upcoming Company Events
As portrayed in its financial statements, the presentation of Accuray Incorporated's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accuray Incorporated's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Accuray Incorporated's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Accuray Incorporated. Please utilize our Beneish M Score to check the likelihood of Accuray Incorporated's management manipulating its earnings.
| 31st of January 2024 Upcoming Quarterly Report | View | |
| 24th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of August 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Build Portfolio with Accuray Incorporated
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.